Human induced pluripotent stem cell-derived inner ear organoids reveal hair cell damage and plasticity after cisplatin and gentamicin exposure
Authors:
- Amy W. A. LucassenALAmy W. A. Lucassen
- Winnie M. C. van Den BoogaardWBWinnie M. C. van Den Boogaard
- Esther FousertEFEsther Fousert
- Jingyuan ZhangJZJingyuan Zhang
- Karl R. KoehlerKKKarl R. Koehler
- Peter Paul G. van BenthemPBPeter Paul G. van Benthem
- Wouter H. van der ValkWouter H. van der Valk
- Heiko LocherHLHeiko Locher
Open Access
- 3 March 2026
- journal article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 19 (6)
Abstract
Ototoxicity is a leading cause of sensory deficits, including hearing loss and balance disorders. Predicting ototoxicity is challenging owing to translatability issues of animal models and limited access to human inner ear tissue. Known ototoxic drugs, such as cisplatin (a chemotherapeutic) and gentamicin (an aminoglycoside antibiotic), cause irreversible damage to sensory hair cells and neurons. Here, we establish human induced pluripotent stem cell (hiPSC)-derived inner ear organoids as an in vitro model for studying ototoxicity. Exposure to cisplatin and gentamicin led to hair cell and neuronal loss, disrupted organoid architecture and increased cell damage, including apoptosis, in a dose-dependent manner. Remarkably, prolonged culture of treated organoids showed re-emergence of otic vesicle structures with sensory hair cells and neurons. SOX10+ otic epithelial cells exhibited increased Ki-67 expression, indicating a potential for developmental plasticity. Our findings demonstrate the value of hiPSC-derived inner ear organoids as a platform for human ototoxicity modeling and provide a basis for testing otoprotective interventions, offering insights into the intrinsic plasticity of developing inner ear cells.Keywords
Funding Information
- Novo Nordisk Fonden (NNF21CC0073729)
- Leids Universitair Medisch Centrum
This publication has 86 references indexed in Scilit:
- Spontaneous hair cell regeneration in the mouse utricle following gentamicin ototoxicityHearing Research, 2009
- Mechanisms of cisplatin-induced ototoxicity and preventionHearing Research, 2007
- CellProfiler: image analysis software for identifying and quantifying cell phenotypesGenome Biology, 2006
- Minocycline prevents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activationNeuroscience, 2005
- Antioxidant Gene Therapy Can Protect Hearing and Hair Cells from OtotoxicityMolecular Therapy, 2004
- Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damageHearing Research, 2003
- The Effect of D-Methionine on Cochlear Oxidative State with and without Cisplatin Administration: Mechanisms of OtoprotectionJournal of the American Academy of Audiology, 2003
- Recent Advances in Understanding Aminoglycoside Ototoxicity and Its PreventionAudiology and Neurotology, 2002
- Global Problem of Drug‐Induced Hearing LossAnnals of the New York Academy of Sciences, 1999
- Brain‐derived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell lossOtolaryngology–Head and Neck Surgery, 1998